{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:32:33Z","timestamp":1774927953150,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.xphs.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T20:39:17Z","timestamp":1456346357000},"page":"2743-2751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Impact of Lipid-Based Drug Delivery Systems on the Transport and Uptake of Insulin Across Caco-2 Cell Monolayers"],"prefix":"10.1016","volume":"105","author":[{"given":"Ping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne M\u00f8rck","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2016.01.006_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(96)01586-6","article-title":"The challenge of proteolytic enzymes in intestinal peptide delivery","volume":"46","author":"Langguth","year":"1997","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2016.01.006_bib2","first-page":"74","article-title":"Enhancement of oral bioavailability of insulin in humans","volume":"30","author":"Badwan","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.xphs.2016.01.006_bib3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1517\/17425247.2012.717068","article-title":"Oral delivery of peptides and proteins using lipid-based drug delivery systems","volume":"9","author":"Li","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2016.01.006_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12248-011-9307-4","article-title":"Absorption enhancers: applications and advances","volume":"14","author":"Aungst","year":"2012","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2016.01.006_bib5","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1023\/A:1018968611962","article-title":"Effects of various protease inhibitors on the intestinal-absorption and degradation of insulin in rats","volume":"11","author":"Yamamoto","year":"1994","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.01.006_bib6","first-page":"1155","article-title":"Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in\u00a0vitro characterization, and improved protection against enzymatic degradation","volume":"6","author":"Niu","year":"2011","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2016.01.006_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2010.07.002","article-title":"Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats","volume":"76","author":"Sharma","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2016.01.006_bib8","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2016.01.006_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-5173(02)00003-0","article-title":"Preparation and in\u00a0vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation","volume":"235","author":"Nazzal","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.01.006_bib10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1745-7254.2006.00424.x","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of a novel oral insulin formulation","volume":"27","author":"Ma","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.xphs.2016.01.006_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejps.2010.01.006","article-title":"Lyophilization of water-in-oil emulsions to prepare phospholipid-based anhydrous reverse micelles for oral peptide delivery","volume":"39","author":"Wang","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2016.01.006_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2008.05.016","article-title":"Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs II. In\u00a0vitro transport study","volume":"362","author":"Rao","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.01.006_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.12.014","article-title":"Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer","volume":"354","author":"Kavimandan","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.01.006_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1023\/A:1022211127890","article-title":"Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers","volume":"20","author":"Foraker","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.01.006_bib15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11095-010-0345-x","article-title":"Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells-towards oral insulin","volume":"28","author":"Thompson","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.01.006_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejpb.2008.03.004","article-title":"Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells","volume":"70","author":"Sadeghi","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2016.01.006_bib17","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1023\/A:1018823100761","article-title":"Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in\u00a0vitro by sodium caprate, a constituent of milk fat","volume":"43","author":"Soderholm","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.xphs.2016.01.006_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1517\/17425247.3.5.685","article-title":"Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET","volume":"3","author":"Leonard","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2016.01.006_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2011.10.003","article-title":"Mechanism underlying insulin uptake in alveolar epithelial cell line RLE-6TN","volume":"672","author":"Oda","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.xphs.2016.01.006_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10611860600649633","article-title":"Indication of transcytotic movement of insulin across human bronchial epithelial cells","volume":"14","author":"Hussain","year":"2006","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.xphs.2016.01.006_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2009.08.010","article-title":"Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis","volume":"140","author":"Roger","year":"2009","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2016.01.006_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00063030-200822040-00002","article-title":"Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation","volume":"22","author":"Woitiski","year":"2008","journal-title":"Biodrugs"},{"key":"10.1016\/j.xphs.2016.01.006_bib23","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/jps.23640","article-title":"Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems","volume":"102","author":"Li","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2016.01.006_bib24","first-page":"45","article-title":"Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles","volume":"62","author":"Rivolta","year":"2011","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.xphs.2016.01.006_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1023\/A:1015393710253","article-title":"Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to caco-2 monolayers mimics particle uptake","volume":"19","author":"Pietzonka","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.01.006_bib26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/03639045.2012.710634","article-title":"Optimization of self nanoemulsifying drug delivery system for poorly water-soluble drug using response surface methodology","volume":"39","author":"Ren","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2016.01.006_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in\u00a0vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2016.01.006_bib28","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s11095-007-9304-6","article-title":"Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in\u00a0vitro lipid digestion monitored by small-angle x-ray scattering","volume":"24","author":"Fatouros","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.01.006_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tiv.2004.02.003","article-title":"Evaluation of different toxicity assays applied to proliferating cells and to stratified epithelium in relation to permeability enhancement with glycocholate","volume":"18","author":"Eirheim","year":"2004","journal-title":"Toxicol In\u00a0Vitro"},{"key":"10.1016\/j.xphs.2016.01.006_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijpharm.2009.07.015","article-title":"Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization","volume":"380","author":"Elnaggar","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.01.006_bib31","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.2042-7158.1996.tb05903.x","article-title":"Effects of enzyme inhibitors and insulin concentration on transepithelial transport of insulin in rats","volume":"48","author":"Bai","year":"1996","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2016.01.006_bib32","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s11095-010-0309-1","article-title":"Nano-emulsions and micro-emulsions: clarifications of the critical differences","volume":"28","author":"Anton","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.01.006_bib33","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1021\/bi002555c","article-title":"Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism","volume":"40","author":"Nielsen","year":"2001","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.xphs.2016.01.006_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2016.01.006_bib35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1023\/A:1018988832492","article-title":"Effect of medium-chain glycerides on physiological-properties of rabbit intestinal epithelium in-vitro","volume":"11","author":"Yeh","year":"1994","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.01.006_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000238580","article-title":"Effect of medium chain glycerides on enteral and rectal absorption of beta-lactam and aminoglycoside antibiotics","volume":"34","author":"Unowsky","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1016\/j.xphs.2016.01.006_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0928-0987(94)90038-8","article-title":"Effects of a new lipid-based drug-delivery system on the absorption of low-molecular-weight heparin (Fragmin) through monolayers of human intestinal epithelial caco-2 cells and after rectal administration to rabbits","volume":"1","author":"Lohikangas","year":"1994","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2016.01.006_bib38","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0022-3565(25)12150-2","article-title":"Mechanisms of absorption enhancement by medium-chain fatty-acids in intestinal epithelial Caco-2 cell monolayers","volume":"275","author":"Lindmark","year":"1995","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2016.01.006_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-3659(99)00031-0","article-title":"Physiological mechanism for enhancement of paracellular drug transport","volume":"62","author":"Hayashi","year":"1999","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2016.01.006_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0022-3565(24)37216-7","article-title":"Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells","volume":"284","author":"Lindmark","year":"1998","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2016.01.006_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1271\/bbb.62.443","article-title":"Physico-chemical properties of fatty acids for assessing the threshold concentration to enhance the absorption of a hydrophilic substance","volume":"62","author":"Kimura","year":"1998","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.xphs.2016.01.006_bib42","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.biomaterials.2012.10.029","article-title":"Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel","volume":"34","author":"Luo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2016.01.006_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00418-008-0406-y","article-title":"Autophagy-physiology and pathophysiology","volume":"129","author":"Uchiyama","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.xphs.2016.01.006_bib44","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1091\/mbc.e04-08-0747","article-title":"Rab9 GTPase regulates late endosome size and requires effector interaction for its stability","volume":"15","author":"Ganley","year":"2004","journal-title":"Mol Biol Cell"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916002690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916002690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T14:05:42Z","timestamp":1748786742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916002690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0022354916002690"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.01.006","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Lipid-Based Drug Delivery Systems on the Transport and Uptake of Insulin Across Caco-2 Cell Monolayers","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}